| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | -5.7% | +22.6% |
| R&D Expense | $5K | — | — |
| SG&A Expense | $2.1M | -3.0% | +40.5% |
| Operating Income | -$1.6M | +45.3% | -25.8% |
| Pre-tax Income | -$2.6M | +17.6% | -65.1% |
| Income Tax | $29K | — | +0.0% |
| Net Income | -$2.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $274K | +13.2% | +6.7% |
| Inventory | $192K | -9.8% | -20.6% |
| Current Assets | $1.1M | -18.8% | -41.9% |
| Total Assets | $18.8M | -2.5% | +10.7% |
| Current Liabilities | $9.2M | -25.8% | +6.8% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.0M | — | — |
| Capital Expenditures | $32K | — | — |
| Investing Cash Flow | -$38K | — | — |
| Financing Cash Flow | $6.7M | — | — |
| Free Cash Flow | -$7.1M | — | — |
| -62.2% |
| EPS (Basic) | -$0.77 | +94.2% | -83.3% |
| EPS (Diluted) | -$0.77 | +94.2% | -83.3% |
| $2.0M |
| -58.8% |
| — |
| Total Liabilities | $13.0M | -22.2% | -23.8% |
| Stockholders' Equity | $5.8M | +122.3% | — |